Search

everythinglearnresearchcommunity

for

Search:↓

Aconiti Ciliare Tuber extract may help hair grow by activating a specific cell signaling pathway.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

FUE provides minimal scarring and quick recovery in hair transplantation, and surgeons not using it may lag in technology.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Bariatric surgery improves skin conditions and metabolism but may cause nutritional deficiencies and hair loss.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Higher iron levels in the blood are not linked to increased hair loss in women.

Female pattern hair loss is more common among Indian women than previously believed.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.